Publications by authors named "Cristina Garcia-Millan"
Background: Although the underlying pathophysiology of sensitive skin remains unknown, it presents clinical symptoms like erythema, burning and dryness associated with other inflammatory dermatoses such as dermatitis or rosacea.
Objective: The aim of the present report was to provide preliminary data about the efficacy of Endoret-Serum (ES) as an autologous therapy for the topical management of sensitive skin alterations.
Materials And Methods: Five patients underwent a daily topical ES treatment that was maintained for three months.
Atopic dermatitis (AD) is a chronic cutaneous inflammatory disorder, characterized by skin barrier disruption. Dermacare is a new cosmetic formulation, which enhances moisturization, reinforces and repairs the skin barrier, and prevents cutaneous microbiota imbalance. To demonstrate its safety and efficacy, a prospective, open-label, and multicenter study was carried out on patients diagnosed with mild to moderate AD.
View Article and Find Full Text PDFIntroduction: Phakomatosis pigmentovascularis (PPV) is a rare syndrome characterized by the association of a vascular nevus with an extensive pigmentary nevus.
Objective: We sought to study and evaluate clinical findings in patients with PPV referred to the laser department of our hospital.
Methods: We revised the clinical findings of 15 patients with PPV and reclassified them according to Happle's new classification.
Article Synopsis
- Epidermal growth factor inhibitors (EGFR) are cancer treatments that often cause acneiform rashes, and while many topical and systemic treatments are noted, none have clear evidence of effectiveness.
- A study involving 6 patients treated with 100 mg of doxycycline daily showed promising results, with 5 patients achieving complete resolution of their rashes in 3 weeks.
- The findings suggest doxycycline could be an effective treatment for EGFR-induced rashes, supporting its use based on the positive outcomes observed in this small study.